Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Nov 12, 2025 · Filed Nov 14, 2025
Gilead Sciences's Corporate Affairs & GC sold $4.4M of Gilead Sciences shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$4,398,591
Shares × reported transaction price
13 days after results of Oct 30, 2025, 90 days before results of Feb 10, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $123.40 on Nov 12, 2025, within 1% of its 52-week high, after an 11% rise over the previous 30 trading days
52-week range $87.75 (Nov 19, 2024) to $124.08 (Oct 21, 2025), 98% of the way up, from 250 adjusted closes. 30 trading days earlier: $111.15 on Oct 1, 2025. Describes the past only, not a forecast
A WARN layoff notice covering 17 workers was filed in California on November 12, 2025.
From the official state WARN list, the same day as the trade. Shown for timing only; the two filings are separate
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +1.3% | -1.9% | +3.2% |
| 30 days | -4.2% | +1.3% | -5.5% |
| 90 days | +21.4% | +1.4% | +20.0% |
| 180 days | +6.4% | +10.5% | -4.0% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Derivative exercise or conversion — not an open-market buy.
